Total Funding
62
Total FundingSeed raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
147896
Creating a new standard of care for gastrin-driven GI malignancies and NETs
About the Company
Sublime Therapeutics is an early stage, privately held biotechnology company based in the San Francisco Bay Area focused on developing proprietary anti-gastrin technology to address significant unmet medical needs in gastrointestinal, pancreatic and neuroendocrine cancers as well as gastrointestinal premalignant conditions such as Barrett’s
Esophagus.
Women Founded
